Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

    August 5, 2026

    HB on the Scene: Rockbridge leaders outline long-term vision for luxury lifestyle platform

    August 5, 2026

    Psychiatric and Medical Comorbidities Common in Methamphetamine Use Disorder

    August 5, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk
    • HB on the Scene: Rockbridge leaders outline long-term vision for luxury lifestyle platform
    • Psychiatric and Medical Comorbidities Common in Methamphetamine Use Disorder
    • Air Force’s Jennifer Green named women’s gymnastics head coach
    • Common advice about kids’ snacking is outdated. Here’s what parents should know
    • Louisiana Tech and LSU Health Shreveport create historic research partnership
    • Psychology says people remember how you made them feel more accurately than what you said
    • Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Wednesday, August 5
    healthylife7.comhealthylife7.com
    Home»Wellness Tips»Eli Lilly stock soars on GLP-1 weight loss drug demand as Kraft Heinz takes a hit
    Wellness Tips

    Eli Lilly stock soars on GLP-1 weight loss drug demand as Kraft Heinz takes a hit

    healthylife7By healthylife7August 5, 2026No Comments2 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Eli Lilly stock soars on GLP-1 weight loss drug demand as Kraft Heinz takes a hit
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    to topclose

    Video
    This video is playing in picture-in-picture.
    On Air
    August 05, 2026
    01:43
    CLIP

    Eli Lilly stock soars on GLP-1 weight loss drug demand as Kraft Heinz takes a hit

    Stuart Varney and Taylor Riggs discuss Eli Lilly’s massive revenue surge driven by GLP-1 obesity drugs Mounjaro and Zepbound, and how the diet craze is negatively impacting food brands like Kraft Heinz

    Eli Lilly stock surges over 7% as soaring demand for GLP-1 weight loss drugs Mounjaro and Zepbound drives massive revenue growth. Stuart Varney and Taylor Riggs analyze the pharmaceutical boom and its surprising ripple effects across the food industry. Riggs notes that processed food giant Kraft Heinz is already experiencing lower sales volume as the obesity drug craze expands

    Tags
    NOW – 11:00 AM
    11:00 AM
    11:30 AM
    12:00 PM
    12:30 PM
    1:00 PM
    Fox Business Channel
    Varney & Company
    10:00 AM – 11:00 AM
    Watch
    Varney & Company
    11:00 AM – 12:00 PM
    The Big Money Show
    12:00 PM – 1:00 PM
    The Big Money Show
    1:00 PM – 1:30 PM
    Fox News Channel
    America’s Newsroom
    10:00 AM – 11:00 AM
    Watch
    The Faulkner Focus
    11:00 AM – 12:00 PM
    Outnumbered
    12:00 PM – 1:00 PM
    America Reports
    1:00 PM – 1:30 PM
    Fox Weather Channel
    Fox Weather
    Live Stream
    Watch
    Fox News Radio
    FOX News Radio Live Channel Coverage
    Live Stream
    Watch
    Fox News Channel Live
    WATCH LIVE: Michigan Senate candidate Abdul El-Sayed holds news conference
    Live Stream
    Watch

    GLP1 Lilly Soars Stock weight
    healthylife7
    • Website

    Related Posts

    Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

    August 5, 2026

    Eli Lilly easily tops quarterly estimates, raises outlook as Zepbound and Mounjaro sales surge

    August 5, 2026

    As the GLP-1 Era Reshapes Weight Management, METAbiotics Launches with Science Designed to Support Long

    August 5, 2026
    Leave A Reply Cancel Reply

    Health
    Wellness Tips

    Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

    By healthylife7August 5, 20260

    Aug 5 (Reuters) – Sales of Eli Lilly’s Zepbound and Mounjaro injectable weight-loss and diabetes drugs soared during the second quarter, easily beating Wall Street estimates and widening the gap with Danish rival Novo Nordisk

    HB on the Scene: Rockbridge leaders outline long-term vision for luxury lifestyle platform

    August 5, 2026

    Psychiatric and Medical Comorbidities Common in Methamphetamine Use Disorder

    August 5, 2026

    Air Force’s Jennifer Green named women’s gymnastics head coach

    August 5, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    Lilly’s Mounjaro, Zepbound sales surge, widening lead over Novo Nordisk

    August 5, 2026

    HB on the Scene: Rockbridge leaders outline long-term vision for luxury lifestyle platform

    August 5, 2026

    Psychiatric and Medical Comorbidities Common in Methamphetamine Use Disorder

    August 5, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.